JAMES F HOWARD

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology CHAPEL HILL, NC NPI 1619082484

General Payments — all program years on this page

$242,689.46

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 203
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $61,943.73 across 33 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $50,914.9716
Travel and Lodging $10,368.926
Food and Beverage $659.8411

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
UCB SA $29,862.609
Alexion Pharmaceuticals, Inc. $17,051.756
ARGENX US, INC. $8,653.118
Amgen Inc. $5,251.393
VERTEX PHARMACEUTICALS INCORPORATED $571.672
UCB, Inc. $386.173
NOVARTIS PHARMACEUTICALS CORPORATION $131.371
Sarepta Therapeutics, Inc. $35.671

By program year

Program yearAmountRecords
2018 $28,582.2035
2019 $9,264.6815
2020 $20,991.2410
2021 $16,099.7712
2022 $47,167.5348
2023 $58,640.3150
2024 $61,943.7333

Records — PY2024 (33)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086946547 Novartis Pharmaceuticals Corporation $131.37 04/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093891879 Alexion Pharmaceuticals, Inc. $1,770.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093909989 Alexion Pharmaceuticals, Inc. $6,224.50 09/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093962351 Alexion Pharmaceuticals, Inc. $207.25 10/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1093995704 Alexion Pharmaceuticals, Inc. $2,360.00 09/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1094045565 Alexion Pharmaceuticals, Inc. $4,720.00 12/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1094050228 Alexion Pharmaceuticals, Inc. $1,770.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105908755 VERTEX PHARMACEUTICALS INCORPORATED $268.34 10/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105919112 VERTEX PHARMACEUTICALS INCORPORATED $303.33 02/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1111602046 Amgen Inc. $111.91 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111602048 Amgen Inc. $39.48 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111602050 Amgen Inc. $5,100.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1113950873 UCB SA $18.50 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113950875 UCB SA $18.50 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113950877 UCB SA $44.39 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113950879 UCB SA $73.98 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113950881 UCB SA $697.17 11/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1113950883 UCB SA $3,575.00 05/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1113950885 UCB SA $7,425.00 04/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1113950889 UCB SA $9,072.56 11/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1126540679 Sarepta Therapeutics, Inc. $35.67 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142114079 ARGENX US, INC. $2,300.00 03/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1142114349 ARGENX US, INC. $20.77 05/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1142114351 ARGENX US, INC. $357.67 05/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1142114513 ARGENX US, INC. $2,187.50 06/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1142115075 ARGENX US, INC. $13.50 05/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1142121491 ARGENX US, INC. $23.67 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142126727 ARGENX US, INC. $2,187.50 10/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1142126769 ARGENX US, INC. $1,562.50 09/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1143057010 UCB, Inc. $43.77 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143057012 UCB, Inc. $118.60 04/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143057014 UCB, Inc. $223.80 05/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1153141999 UCB SA $8,937.50 02/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.